Scalper1 News
Irish drugmaker Shire (SHPG) beat Wall Street’s Q3 estimates and raised its guidance Friday, sending its beleaguered stock up more than 5% on the stock market today to 194.84. Earnings excluding one-time items rose 60% over the year-earlier quarter to $2.93 a share, 46 cents above analysts’ consensus, according to Thomson Reuters. Revenue increased 32% to $1.6 billion, some $140 million more than the Street expected. It was the fifth-straight Scalper1 News
Scalper1 News